Merck KGaA's US research site to cut 20 jobs amid broader R&D downsizing
Merck KGaA's North American division, EMD Serono, announced it will lay off 20 employees at its Billerica, Massachusetts research site.
The cuts are slated to take effect in the second half of October, according to a state labor filing, and follow a review of the site's R&D needs.
The move comes as the company enforces an onsite-work policy that could force up to 70 of the 280-person workforce to leave if they do not relocate, though numbers choosing not to move have not been disclosed.
The layoffs are part of a broader trend of Merck KGaA scaling back its U.S. R&D operations and shifting toward external innovation partnerships.
This writeup was produced by pharmadog from original reporting by Fierce Biotech.
Original headline: “Merck KGaA lays off 20 staffers in latest blow to US research team”
read at Fierce Biotech ↗
comments(0)
5-min edit window · permanent after that